Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways
Lubna H. Abdullah, Jessica R. Evans, T. Tiffany Wang, Amina A. Ford, Alexander M. Makhov, Kristine Nguyen, Raymond D. Coakley, Jack D. Griffith, C. William Davis, Stephen T. Ballard, Mehmet Kesimer
Lubna H. Abdullah, Jessica R. Evans, T. Tiffany Wang, Amina A. Ford, Alexander M. Makhov, Kristine Nguyen, Raymond D. Coakley, Jack D. Griffith, C. William Davis, Stephen T. Ballard, Mehmet Kesimer
View: Text | PDF
Research Article Pulmonology

Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways

  • Text
  • PDF
Abstract

In cystic fibrosis (CF), airway mucus becomes thick and viscous, and its clearance from the airways is impaired. The gel-forming mucins undergo an ordered “unpacking/maturation” process after granular release that requires an optimum postsecretory environment, including hydration and pH. We hypothesized that this unpacking process is compromised in the CF lung due to abnormal transepithelial fluid transport that reduces airway surface hydration and alters ionic composition. Using human tracheobronchial epithelial cells derived from non-CF and CF donors and mucus samples from human subjects and domestic pigs, we investigated the process of postsecretory mucin unfolding/maturation, how these processes are defective in CF airways, and the probable mechanism underlying defective unfolding. First, we found that mucins released into a normal lung environment transform from a compact granular form to a linear form. Second, we demonstrated that this maturation process is defective in the CF airway environment. Finally, we demonstrated that independent of HCO3− and pH levels, airway surface dehydration was the major determinant of this abnormal unfolding process. This defective unfolding/maturation process after granular release suggests that the CF extracellular environment is ion/water depleted and likely contributes to abnormal mucus properties in CF airways prior to infection and inflammation.

Authors

Lubna H. Abdullah, Jessica R. Evans, T. Tiffany Wang, Amina A. Ford, Alexander M. Makhov, Kristine Nguyen, Raymond D. Coakley, Jack D. Griffith, C. William Davis, Stephen T. Ballard, Mehmet Kesimer

×

Figure 5

Distribution of mucin in CF-like pig tracheas after treatments.

Options: View larger image (or click on image) Download as PowerPoint
Distribution of mucin in CF-like pig tracheas after treatments.
Four inh...
Four inhibitor pretreatment combinations were used: (a) 100 μM bumetanide plus 100 μM dimethylamiloride (DMA); (b) 100 μM bumetanide; and (c) 100 μM DMA as well as (d) 100 μM ACh, which was added to induce mucus secretion. The control group was treated only with 100 μM ACh. (A) In the control mucus, the majority of the MUC5B population was recovered on the low-density side of the gradient (top: fractions 3–5) in a linear form, while only a small proportion of the MUC5B was recovered in the medium-density region (middle: fractions 6–9) in a semicompact/semilinear form, and less than 1%–3% of the MUC5B was recovered in the high-density region of the gradient (bottom: fraction 12) in a compact form. In contrast, mucus from the bumetanide+DMA pretreatment group had an abnormal distribution of MUC5B forms: 10%–25% were in a linear form, 20%–30% were in a semicompact/semilinear form, and approximately 50% were in a compact form in the high-density region (A). (B) Mucus samples from tracheas that were pretreated with only bumetanide also yielded an abnormal Muc5b profile, as did samples pretreated with DMA+bumetanide. (C) DMA treatment slightly but not significantly changed the Muc5b profile. Significant (P = 0.005) decreases were observed in the linear form after (B) bumetanide alone and (A) DMA+bumetanide pretreatments. The proportion of the compact form significantly (P = 0.005) increased after bumetanide alone and DMA+bumetanide pretreatments. (D–F) Analysis of the linear and compact forms in these treatments compared with the nontreated samples is displayed as a scatter plot. Bars represent mean ± SD (*P = 0.01, **P = 0.005). Statistical significance was determined using 1-way ANOVA. NT, not treated.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts